RNTX
Rein Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Rein Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No changes.
No changes.
No thesis.
Rein Therapeutics Inc is a biopharmaceutical company that focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. They are headquartered in Austin, Texas.
Rein Therapeutics Inc is a biopharmaceutical company that focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. They are headquartered in Austin, Texas.
—
Rein Therapeutics, Inc.
0.66
+0.02 · +3.45%
post 0.67 +1.95%
Annual filing, covered
10-K parsed · Mar 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
—
| Manager | Value | % base | |
|---|---|---|---|
| Voss Capital | $5.5M | 12.88% | +19.91% |
| Cable Car Capital | $5.4M | 12.72% | +1136.90% |
| ADAR1 | $4.7M | 11.02% | new |
| Vanguardindex-like | $3.5M | 8.27% | +238.29% |
| BIOS | $3.1M | 7.30% | +50.44% |
| Manager | Value | % base | |
|---|---|---|---|
| Voss Capital | $5.5M | 12.88% | +19.91% |
| Cable Car Capital | $5.4M | 12.72% | +1136.90% |
| ADAR1 | $4.7M | 11.02% | new |
| Vanguardindex-like | $3.5M | 8.27% | +238.29% |
| BIOS | $3.1M | 7.30% | +50.44% |
Tall tick = annual report · Source: EDGAR
Largest filed tie
—
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Rein Therapeutics, Inc..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Rein Therapeutics, Inc..
Expected move
No implied move.
—
—